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A 41-year-old woman developed progressive dyspnea dur-ing a 3-month period. She was initially diagnosed with
asthma and treated medically without significant relief. Chest
x-ray was unremarkable. She reported feeling like her “throat
was closing up.” Pulmonary function demonstrated a severe
obstructive pattern. Her dyspnea continued to progress and
eventually the patient reportedly became apneic at home and
required resuscitation. A computed tomography scan demon-
strated a near obstructing lesion of the distal trachea (Figure
1). She was emergently transferred to our institution. Bron-
choscopy revealed a near obstructing polypoid mass 7 cm
from the vocal cords (Figure 2). The lesion was detached
from the tracheal wall with a snare cautery. The mass was
located 3 cm proximal to the carina and 7 cm distal to the
vocal cords. The mass measured 2 1.8 1.3 cm and frozen
section analysis revealed a poorly differentiated carcinoma.
Five days later, she underwent a sternotomy with resection of
2 cm of trachea, 3 cm proximal to the carina. Subsequently,
final pathology demonstrated an anaplastic lymphoma kinase
positive large B-cell lymphoma. Resection margins were free
of tumor. Immunohistochemistry was positive for anaplastic
lymphoma kinase-1, CD138, and MUM1. Ebstein-Barr en-
coded RNA was negative as was CD30 and CD20. One
paratracheal lymph node was involved out of 17 sampled.
Tumor was stage II by the Ann Arbor staging system. Six
cycles of cyclophosphamide, doxorubicin, vincristine, and
prednisolone chemotherapy were administered postopera-
tively. At 4-month follow-up, the patient is alive and well
without clinical or radiographic evidence of recurrent disease.
Primary tumors of the trachea represent about 0.1% of
all malignancies.1 Primary non-Hodgkin’s lymphoma of the
trachea is even more uncommon, representing 0.23% of all
tracheal tumors.2 The most comprehensive review of the
literature identified only 28 primary tracheal lymphomas
from 1973 to 2000.3 Median age of presentation was 44 years
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FIGURE 1. Computed tomography of the neck demonstrates
a near obstructing endoluminal mass in the distal trachea.
FIGURE 2. Flexible bronchoscopy demonstrated a fleshy ap-
pearing endoluminal tumor 7 cm distal to the vocal cords,
measuring 1.5 cm in length and 3.5 cm above the tracheal
carina.
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(range of 4–81). Common presenting symptoms include
dyspnea, cough, stridor, and wheezing. Hemoptysis is un-
common given the submucosal location of tracheal lympho-
mas. Patients are frequently treated erroneously for asthma or
bronchitis on initial presentation. Symptomatic progression
leads to bronchoscopy or computed tomography scan. Tra-
cheal lymphomas may also present with impending airway
obstruction as seen in our patient. Airway obstruction has
been observed in 87% of patients with 54% requiring an
emergent intervention.3
The first management priority is establishment of an
airway by coring out endoluminal tumor. This also estab-
lishes a diagnosis. Given the rarity of primary tracheal lym-
phomas, management remains anecdotal. Surgery, chemo-
therapy, and radiation have all been used either alone or in
combination. Combined chemotherapy and radiation is gen-
erally administered for localized non-Hodgkin’s lymphoma.
However, surgery is often undertaken for early stage disease
in locations such as the small intestine and epidural space,
either alone or in combination with chemotherapy. A primary
surgical approach, as undertaken in this case, has been used
successfully in treatment of primary tracheal lymphomas.2–4
Others have undergone successful treatment with chemother-
apy.3,5 Outcomes are generally favorable, however, 22% of
patients die of disease progression with histologic subtype
possibly impacting prognosis.4
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